Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
A new bronchoscopic catheter for the transbronchial ablation of pulmonary nodulesSeyer Safi, Jan Op den Winkel, Steve Kramer, et al.
Insights Into Imaging|January 11, 2014
Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasmsMarcel Koenigkam-Santos, Gregor Sommer, Michael Puderbach, et al.
Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patientsYoshikane Yamauchi, Seyer Safi, Thomas Muley, et al.
World Journal of Surgical Oncology|August 8, 2024
Peri- and postoperative morbidity and mortality in older patients with non-small cell lung cancer: a matched-pair studySeyer Safi, Maximilian Robert Gysan, Dorothea Weber, et al.
Oncoimmunology|November 18, 2017
Functional T cells targeting tumor-associated antigens are predictive for recurrence-free survival of patients with radically operated non-small cell lung cancerSeyer Safi, Yoshikane Yamauchi, Anchana Rathinasamy, et al.
World Journal of Urology|October 31, 2020
Short-term and long-term outcomes after resection of thoracic growing teratoma syndromeStefan Sponholz, Kyriaki Chalepaki Ntelli, Georgios Karaindros, et al.
BMC Cancer|December 22, 2015
A randomized phase II study of radiation induced immune boost in operable non-small cell lung cancer (RadImmune trial)Seyer Safi, Philipp Beckhove, Arne Warth, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
The dynamic pattern of recurrence in curatively resected non-small cell lung cancer patients: Experiences at a single institutionYoshikane Yamauchi, Thomas Muley, Seyer Safi, et al.
Plos One|April 10, 2015
Development and validation of a risk score for predicting death after pneumonectomySeyer Safi, Axel Benner, Janos Walloschek, et al.
BMC Cancer|August 9, 2025
Circulating Hsp70: a tumor biomarker for lymph node metastases and early relapse in thoracic cancerDominik Lobinger, Nicholas Taylor, Verena Messner, et al.
Pageof 5